ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,537.02
      0.51%
      US Tech 100
      19,641.60
      0.83%
      Dow Jones
      39,308.00
      -0.06%
      Brent Oil
      86.915
      -0.48%
      Bitcoin
      54,358.71
      -4.62%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Taysha Gene Therapies Inc (TSHA)

      7. Taysha Gene Therapies Inc (TSHA) News

      TSHA

      Taysha Gene Therapies (TSHA)

      Taysha Gene Therapies Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:TSHA
      DateTimeSourceHeadlineSymbolCompany
      05/08/20234:02PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TSHATaysha Gene Therapies Inc
      05/04/20238:00AMGlobeNewswire Inc.Taysha Gene Therapies to Release First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 11NASDAQ:TSHATaysha Gene Therapies Inc
      04/27/20234:52PMGlobeNewswire Inc.Taysha Gene Therapies Announces Presentation on New Preclinical Data for TSHA-102 in Rett Syndrome at Upcoming American Society of Gene and Cell Therapy 26th Annual MeetingNASDAQ:TSHATaysha Gene Therapies Inc
      04/27/20234:10PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TSHATaysha Gene Therapies Inc
      04/27/20234:09PMEdgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:TSHATaysha Gene Therapies Inc
      03/29/20236:05AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TSHATaysha Gene Therapies Inc
      03/28/20235:06PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:TSHATaysha Gene Therapies Inc
      03/28/20234:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TSHATaysha Gene Therapies Inc
      03/28/20234:01PMGlobeNewswire Inc.Taysha Gene Therapies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
      03/15/20234:01PMGlobeNewswire Inc.Taysha Gene Therapies to Release Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call and Webcast on March 28NASDAQ:TSHATaysha Gene Therapies Inc
      02/09/202312:43PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TSHATaysha Gene Therapies Inc
      01/31/20234:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TSHATaysha Gene Therapies Inc
      01/31/20234:01PMGlobeNewswire Inc.Taysha Gene Therapies Provides Update on TSHA-120 Program in Giant Axonal Neuropathy and a 2023 Corporate OutlookNASDAQ:TSHATaysha Gene Therapies Inc
      01/04/20234:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TSHATaysha Gene Therapies Inc
      01/04/20234:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TSHATaysha Gene Therapies Inc
      12/23/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TSHATaysha Gene Therapies Inc
      12/16/20226:18PMGlobeNewswire Inc.Taysha Gene Therapies Announces Executive Leadership ChangesNASDAQ:TSHATaysha Gene Therapies Inc
      11/29/20224:01PMGlobeNewswire Inc.Taysha Gene Therapies to Participate in JMP Securities Hematology and Oncology SummitNASDAQ:TSHATaysha Gene Therapies Inc
      11/10/202211:57AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TSHATaysha Gene Therapies Inc
      11/10/202212:35AMTipRanksTaysha Gene Therapies (TSHA) Gets a Buy from JMP SecuritiesNASDAQ:TSHATaysha Gene Therapies Inc
      11/09/202211:17PMTipRanksRobert W. Baird Sticks to Their Buy Rating for Taysha Gene Therapies (TSHA)NASDAQ:TSHATaysha Gene Therapies Inc
      11/09/20227:51AMTipRanksAnalysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Avidity Biosciences (RNA)NASDAQ:TSHATaysha Gene Therapies Inc
      11/08/20229:03AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TSHATaysha Gene Therapies Inc
      11/08/20227:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TSHATaysha Gene Therapies Inc
      11/08/20227:00AMGlobeNewswire Inc.Taysha Gene Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:TSHATaysha Gene Therapies Inc
      11/07/20228:46AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:TSHATaysha Gene Therapies Inc
      11/03/20228:26PMTipRanksThese 2 Stocks May Be Reaching a Bottom; Insiders Are Buying the DipNASDAQ:TSHATaysha Gene Therapies Inc
      11/02/20227:00AMGlobeNewswire Inc.Taysha Gene Therapies to Release Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 8NASDAQ:TSHATaysha Gene Therapies Inc
      10/31/20224:03PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:TSHATaysha Gene Therapies Inc
      10/31/20228:46AMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:TSHATaysha Gene Therapies Inc
       Showing the most relevant articles for your search:NASDAQ:TSHA